Healthcare Value Capital as of March 31, 2013
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 49 positions in its portfolio as reported in the March 2013 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
AstraZeneca (AZN) | 8.5 | $11M | 222k | 49.98 | |
Forest Laboratories | 5.2 | $6.8M | 179k | 38.04 | |
Abbvie (ABBV) | 4.7 | $6.2M | 153k | 40.78 | |
Quest Diagnostics Incorporated (DGX) | 4.7 | $6.1M | 108k | 56.46 | |
GlaxoSmithKline | 4.5 | $6.0M | 127k | 46.91 | |
Cardinal Health (CAH) | 3.9 | $5.1M | 123k | 41.63 | |
Becton, Dickinson and (BDX) | 3.6 | $4.8M | 50k | 95.62 | |
Merck & Co (MRK) | 3.4 | $4.4M | 100k | 44.20 | |
Qlt | 3.3 | $4.3M | 483k | 8.84 | |
Auxilium Pharmaceuticals | 3.1 | $4.1M | 239k | 17.29 | |
Cornerstone Therapeutics | 3.1 | $4.1M | 576k | 7.07 | |
NuVasive | 3.1 | $4.0M | 190k | 21.31 | |
Pfizer (PFE) | 3.0 | $4.0M | 138k | 28.86 | |
Novartis (NVS) | 2.7 | $3.6M | 50k | 71.24 | |
Supernus Pharmaceuticals (SUPN) | 2.7 | $3.6M | 636k | 5.62 | |
Sagent Pharmaceuticals | 2.7 | $3.5M | 201k | 17.55 | |
Express Scripts Holding | 2.7 | $3.5M | 61k | 57.63 | |
Novo Nordisk A/S (NVO) | 2.5 | $3.2M | 20k | 161.50 | |
Sanofi-Aventis SA (SNY) | 2.2 | $2.9M | 56k | 51.09 | |
Hca Holdings (HCA) | 1.9 | $2.4M | 60k | 40.63 | |
Walgreen Company | 1.8 | $2.4M | 50k | 47.68 | |
Teva Pharmaceutical Industries (TEVA) | 1.8 | $2.4M | 60k | 39.68 | |
Shire | 1.7 | $2.3M | 25k | 91.36 | |
CryoLife (AORT) | 1.7 | $2.3M | 380k | 6.01 | |
Impax Laboratories | 1.6 | $2.1M | 135k | 15.44 | |
Obagi Medical Products | 1.5 | $2.0M | 100k | 19.75 | |
Biogen Idec (BIIB) | 1.5 | $1.9M | 10k | 192.60 | |
Accuray Incorporated (ARAY) | 1.4 | $1.9M | 402k | 4.64 | |
Centene Corporation (CNC) | 1.3 | $1.8M | 40k | 44.05 | |
Covance | 1.3 | $1.7M | 23k | 74.33 | |
Medicines Company | 1.2 | $1.6M | 48k | 33.42 | |
Gilead Sciences (GILD) | 1.1 | $1.5M | 30k | 48.93 | |
Tenet Healthcare Corporation (THC) | 1.1 | $1.4M | 30k | 47.57 | |
Community Health Systems (CYH) | 1.1 | $1.4M | 30k | 47.40 | |
St. Jude Medical | 1.1 | $1.4M | 35k | 40.43 | |
Humana (HUM) | 1.1 | $1.4M | 20k | 69.10 | |
Hospira | 1.0 | $1.3M | 40k | 32.82 | |
Allscripts Healthcare Solutions (MDRX) | 0.9 | $1.2M | 91k | 13.59 | |
Zimmer Holdings (ZBH) | 0.9 | $1.2M | 15k | 75.19 | |
WellPoint | 0.8 | $993k | 15k | 66.20 | |
ACCRETIVE Health | 0.7 | $914k | 90k | 10.16 | |
Sunesis Pharmaceuticals | 0.5 | $603k | 110k | 5.47 | |
Molina Healthcare (MOH) | 0.3 | $463k | 15k | 30.87 | |
Zogenix | 0.3 | $376k | 209k | 1.80 | |
Anacor Pharmaceuticals In | 0.2 | $323k | 50k | 6.46 | |
PROLOR Biotech | 0.2 | $293k | 58k | 5.06 | |
Arena Pharmaceuticals | 0.2 | $205k | 25k | 8.20 | |
ZIOPHARM Oncology | 0.1 | $137k | 75k | 1.83 | |
Dynavax Technologies Corporation | 0.1 | $111k | 50k | 2.22 |